Primary |
Breast Cancer |
70.9% |
Product Used For Unknown Indication |
5.4% |
Drug Use For Unknown Indication |
2.9% |
Breast Cancer Female |
2.8% |
Breast Cancer In Situ |
2.7% |
Breast Cancer Metastatic |
2.7% |
Breast Cancer Stage I |
1.4% |
Breast Cancer Stage Ii |
1.4% |
Hypertension |
1.3% |
Prophylaxis |
1.2% |
Diabetes Mellitus |
1.2% |
Blood Pressure Increased |
0.8% |
Breast Cancer Recurrent |
0.8% |
Depression |
0.8% |
Hypothyroidism |
0.8% |
Osteoporosis |
0.6% |
Pain |
0.6% |
Anxiety |
0.5% |
Blood Cholesterol Increased |
0.5% |
Epilepsy |
0.5% |
|
Thrombosis |
10.2% |
Vaginal Haemorrhage |
10.2% |
Breast Cancer Recurrent |
6.4% |
Uterine Polyp |
6.4% |
Weight Increased |
6.4% |
Pulmonary Embolism |
6.1% |
Deafness |
5.1% |
Uterine Cancer |
5.1% |
Cerebrovascular Accident |
4.8% |
Visual Acuity Reduced |
4.8% |
Uterine Leiomyoma |
4.5% |
Deep Vein Thrombosis |
3.8% |
Disease Progression |
3.8% |
Endometrial Cancer |
3.8% |
Maculopathy |
3.8% |
Ovarian Cancer |
3.5% |
Weight Decreased |
3.5% |
Disease Recurrence |
2.6% |
Sinus Bradycardia |
2.6% |
Visual Disturbance |
2.6% |
|
Secondary |
Breast Cancer |
59.4% |
Prophylaxis |
6.1% |
Breast Cancer Metastatic |
4.2% |
Drug Use For Unknown Indication |
4.1% |
Hypertension |
3.9% |
Product Used For Unknown Indication |
3.5% |
Premedication |
2.4% |
Malignant Melanoma Stage Iv |
2.3% |
Metastases To Bone |
2.0% |
Accidental Exposure |
1.4% |
Breast Cancer Female |
1.3% |
Depression |
1.3% |
Neoplasm |
1.3% |
Menopause |
1.1% |
Breast Cancer Stage Ii |
1.1% |
Pain |
1.0% |
Ill-defined Disorder |
1.0% |
Osteoporosis |
0.9% |
Chemotherapy |
0.8% |
Hormone Therapy |
0.8% |
|
Uterine Polyp |
8.5% |
Pyrexia |
7.5% |
Weight Increased |
7.5% |
Weight Decreased |
7.0% |
Vaginal Haemorrhage |
6.6% |
Hepatic Failure |
6.1% |
Hypothyroidism |
5.6% |
Acute Myeloid Leukaemia |
5.2% |
Pulmonary Embolism |
5.2% |
Osteonecrosis |
4.7% |
Aplastic Anaemia |
4.2% |
Uterine Leiomyoma |
4.2% |
Vitreous Floaters |
4.2% |
Breast Cancer |
3.8% |
Arthralgia |
3.3% |
Depression |
3.3% |
Interstitial Lung Disease |
3.3% |
Neoplasm Malignant |
3.3% |
Osteonecrosis Of Jaw |
3.3% |
Pulmonary Hypoplasia |
3.3% |
|
Concomitant |
Breast Cancer |
31.4% |
Metastases To Bone |
10.0% |
Breast Cancer Metastatic |
9.0% |
Drug Use For Unknown Indication |
6.8% |
Product Used For Unknown Indication |
6.4% |
Depression |
5.0% |
Pain |
4.8% |
Osteoporosis |
4.7% |
Hypertension |
3.9% |
Prophylaxis |
2.9% |
Neoplasm Malignant |
2.1% |
Menopause |
2.1% |
Anxiety |
2.0% |
Osteopenia |
1.4% |
Rheumatoid Arthritis |
1.4% |
Chemotherapy |
1.3% |
Arthritis |
1.3% |
Insomnia |
1.2% |
Anaemia |
1.1% |
Diabetes Mellitus |
1.1% |
|
Weight Decreased |
16.0% |
Vomiting |
13.3% |
Tooth Extraction |
9.3% |
Weight Increased |
7.9% |
Osteonecrosis |
6.3% |
Breast Cancer |
4.1% |
Urinary Tract Infection |
4.0% |
Toothache |
3.9% |
Viral Infection |
3.9% |
Wound Drainage |
3.8% |
Wheezing |
3.3% |
Pain |
3.2% |
Wound Dehiscence |
3.1% |
Pain In Extremity |
2.6% |
Walking Aid User |
2.6% |
White Blood Cell Count Decreased |
2.6% |
X-ray Abnormal |
2.6% |
Hypertension |
2.5% |
Nausea |
2.5% |
Osteonecrosis Of Jaw |
2.5% |
|
Interacting |
Breast Cancer |
45.8% |
Drug Use For Unknown Indication |
25.3% |
Breast Cancer Metastatic |
4.8% |
Depression |
4.8% |
Metastasis |
3.6% |
Breast Disorder |
2.4% |
Deep Vein Thrombosis |
2.4% |
Prophylactic Chemotherapy |
2.4% |
Anxiolytic Therapy |
1.2% |
Cancer Hormonal Therapy |
1.2% |
Dilatation Ventricular |
1.2% |
Epilepsy |
1.2% |
Hypokinesia |
1.2% |
Insomnia |
1.2% |
Mental Disorder |
1.2% |
|
Drug Interaction |
26.9% |
Weight Decreased |
11.5% |
Breast Cancer |
3.8% |
Drug Hypersensitivity |
3.8% |
Drug Level Decreased |
3.8% |
Hypertension |
3.8% |
International Normalised Ratio Increased |
3.8% |
Labelled Drug-drug Interaction Medication Error |
3.8% |
Major Depression |
3.8% |
Non-cardiac Chest Pain |
3.8% |
Osteonecrosis |
3.8% |
Osteoporosis |
3.8% |
Sinus Bradycardia |
3.8% |
Sleep Disorder |
3.8% |
Suicide Attempt |
3.8% |
Uterine Disorder |
3.8% |
Venous Thrombosis Limb |
3.8% |
Vomiting |
3.8% |
|